Ladenburg Thalmann initiated coverage on Calithera Biosciences with a new price target

1/31/22 7:56:32 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Ladenburg Thalmann initiated coverage of Calithera Biosciences with a rating of Buy and set a new price target of $4.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$CALA

Date	Price Target	Rating	Analyst
1/31/2022	$4.00	Buy	Ladenburg Thalmann
1/20/2022	$1.00 → $3.00	Market Perform → Outperform	SVB Leerink
11/8/2021		Buy → Neutral	HC Wainwright & Co.
11/5/2021		Outperform → Market Perform	William Blair